ENDOVASKULÄRE VORRICHTUNG

European patent · EP4054445 · In force

Register entry

Publication number
EP4054445
Application number
EP20816409
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 6, 2020
Published
Sep 14, 2022
Granted
Sep 13, 2023
Protection ends at the latest
Nov 5, 2040
Next annual fee due
Nov 30, 2026
IPC classes
A61B 17/22 (2006.01)
A61B 17/3207 (2006.01)
Priority
WO PCT/EP2019/080449 06.11.2019
GB 202006665 05.05.2020
PCT application
PCT/EP2020/081386 06.11.2020
PCT publication
WO2021/089847 14.05.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Jul 24, 2024

    Change

    Published in Swissreg on 24.07.2024

  4. Feb 12, 2024

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 12.02.2024

  5. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  6. Sep 13, 2023

    Granted

    Published in Swissreg on 13.09.2023

Parties

Holder

Versono Medical Limited

SSL Buildings Parkmore West Business Park, Galway, H91 HP4F, IE

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

TARPEY, Brian

Galway, H91 HP4F, IE

O'DONOGHUE, Hugh

Galway, H91 HP4F, IE

DOLAN, Finbar

Galway, H91 HP4F, IE

CONNOLLY, Pat

Galway, H91 HP4F, IE

MOONEY, Ivan

Galway, H91 HP4F, IE

SMEDLEY, Jim

Galway, H91 HP4F, IE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.